Version · Cosmetics Regulation
Version in force
Made by Regulation (EU) 2026/78 32026R0078 on EUR-Lex (external, EUR-Lex)
Version 40 of 41 recorded for Cosmetics Regulation.
First seen by emendrix on , when it first read this version; that is not a legal date.
4 changes in this version
Consolidated versions 02009R1223-20250901 → 02009R1223-20260501. v1 is the previous version, v2 this one.
What changed
Annex II LIST OF SUBSTANCES PROHIBITED IN COSMETIC PRODUCTS, Modified§
No explanation shipped — the difference between the two versions lies beyond the characters this stage can show, so no explanation was requested.
Each CAS and EC number in these tables links to its own page, which lists every entry that prints it across the acts this record holds.
15 entries added, 2 amended, 0 removed.
3 rows carry no key and are not compared.
15 entries added
| Identifiers | Reference number | Substance identification | ||
|---|---|---|---|---|
| Chemical name/INN | CAS number | EC number | ||
| a | b | c | d | |
| Reference number 1752 | 1752 | Multi-walled Carbon Tubes (synthetic graphite in tubular shape) with a geometric tube diameter range ≥ 30 nm to < 3 μm and a length ≥ 5 μm and aspect ratio > 3:1, including Multi-Walled Carbon Nanotubes, MWC(N)T | — | — |
| Reference number 1753 | 1753 | reaction mass of 1,3-dioxan-5-ol and 1,3-dioxolan-4-ylmethanol | — | — |
| Reference number 1754CAS 127-06-0EC 204-820-1 | 1754 | Acetone oxime | 127-06-0 | 204-820-1 |
| Reference number 1755CAS 119344-86-4EC 438-340-0 | 1755 | 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one | 119344-86-4 | 438-340-0 |
| Reference number 1756CAS 26761-45-5EC 247-979-2 | 1756 | 2,3-epoxypropyl neodecanoate | 26761-45-5 | 247-979-2 |
| Reference number 1757CAS 177406-68-7 | 1757 | Benthiavalicarb-isopropyl (ISO); isopropyl [(S)-1-{[(R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]carbamoyl}-2-methylpropyl]carbamate | 177406-68-7 | — |
| Reference number 1758CAS 2386-87-0EC 219-207-4 | 1758 | 7-oxabicyclo[4.1.0]hept-3-ylmethyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate | 2386-87-0 | 219-207-4 |
| Reference number 1759CAS 52556-42-0EC 258-004-5 | 1759 | Sodium 3-(allyloxy)-2-hydroxypropanesulphonate | 52556-42-0 | 258-004-5 |
| Reference number 1760CAS 89-61-2EC 201-923-3 | 1760 | 1,4-dichloro-2-nitrobenzene | 89-61-2 | 201-923-3 |
| Reference number 1761CAS 67306-00-7 | 1761 | Fenpropidin (ISO); (R,S)-1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine | 67306-00-7 | — |
| Reference number 1762CAS 110-26-9EC 203-750-9 | 1762 | N,N’-methylenediacrylamide | 110-26-9 | 203-750-9 |
| Reference number 1763CAS 3006-82-4EC 221-110-7 | 1763 | tert-butyl 2-ethylperoxyhexanoate | 3006-82-4 | 221-110-7 |
| Reference number 1764CAS 121-43-7EC 204-468-9 | 1764 | Trimethyl borate | 121-43-7 | 204-468-9 |
| Reference number 1765CAS 87392-12-9 | 1765 | S-metolachlor (ISO); 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide; (RaSa)-2-chloro-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]acetamide [contains 80-100 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide and 0-20 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2R)-1-methoxypropan-2-yl]acetamide] | 87392-12-9 | — |
| Reference number 1766CAS 175013-18-0 | 1766 | Pyraclostrobin (ISO); methyl N-(2-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl}phenyl) N-methoxy carbamate | 175013-18-0 | — |
2 entries amended
| Identifiers | Version | Reference number | Substance identification | ||
|---|---|---|---|---|---|
| Chemical name/INN | CAS number | EC number | |||
| a | b | c | d | ||
| Reference number 1397CAS 10332-33-9CAS 10486-00-7CAS 11138-47-9CAS 12040-72-1CAS 121-43-7CAS 13517-20-9CAS 15120-21-5CAS 37244-98-7CAS 7632-04-4EC 204-468-9EC 231-556-4EC 234-390-0EC 239-172-9 | Before | 1397 | 239-172-9 [1] | ||
| After | 1397 | Perboric acid (H3BO2(O2)), monosodium salt trihydrate [1] | 13517-20-9 [1] | 239-172-9 [1] | |
| Perboric acid, sodium salt, tetrahydrate [2] | 37244-98-7 [2] | 234-390-0 [2] | |||
| Perboric acid (HBO(O2)), sodium salt, tetrahydrate [3] | 10486-00-7 [3] | — [3] | |||
| Sodium peroxoborate, hexahydrate [4] | — [4] | — [4] | |||
| Sodium perborate [5] | 15120-21-5 [5] | 239-172-9 [5] | |||
| Sodium peroxometaborate; sodium peroxoborate [6] | 7632-04-4/10332-33-9/10486-00-7 [6] | 231-556-4 [6] | |||
| Perboric acid, sodium salt [7] | 11138-47-9 [7] | 234-390-0 [7] | |||
| Perboric acid, sodium salt, monohydrate [8] | 12040-72-1 [8] | 234-390-0 [8] | |||
| Perboric acid (HBO(O2)), sodium salt, monohydrate [9] | 10332-33-9 [9] | — [9] | |||
| Trimethyl borate | 121-43-7 [10] | 204-468-9 [10] | |||
| Reference number 1727CAS 7440-22-4EC 231-131-3 | Before | 1727 | 7440-22-4 | 231-131-3 | |
| After | 1727 | Silver (nano) [1 nm < particle diameter ≤ 100 nm] Silver (massive) [particle diameter ≥ 1 mm] | 7440-22-4 | 231-131-3 | |
Text from EUR-Lex, before and after
Previous version, in force 1 September 2025 02009R1223-20250901 → this version, in force 1 May 2026 02009R1223-20260501
ANNEX II
LIST OF SUBSTANCES PROHIBITED IN COSMETIC PRODUCTS
OJ L 159, 29.6.1996, p. 1Modified INNM-name.OJ L 273, 10.10.2002, p. 1.for the individual ingredient see reference number 364 in Annex II.for the individual ingredient see reference number 413 in Annex II.From 23 … 14,526 unchanged words … salt [8] 1330-43-4 [8] 215-540-4 [8]
Tetraboron disodium heptaoxide, hydrate [9] 12267-73-1 [9] 235-541-3 [9]
Orthoboric acid, sodium salt [10] 13840-56-7 [10] 237-560-2 [10]
Disodium tetraborate decahydrate; borax decahydrate [11] 1303-96-4 [11] 215-540-4 [11]
Disodium tetraborate pentahydrate; borax pentahydrate [12] 12179-04-3 [12] 215-540-4 [12]
1397 Perboric acid (H3BO2(O2)), monosodium salt trihydrate [1] 13517-20-9 [1] 239-172-9 [1]
Perboric acid, sodium salt, tetrahydrate [2] 37244-98-7 [2] 234-390-0 [2]
Perboric acid (HBO(O2)), sodium salt, tetrahydrate [3] 10486-00-7 [3] — [3]
Sodium peroxoborate, hexahydrate [4] — [4] — [4]
Sodium perborate [1] [5] 15120-21-5 [5] 239-172-9 [5]
Sodium peroxometaborate; sodium peroxoborate [2] 15120-21-5 [1] 239-172-9 [1]
7632-04-4 [2] [6] 7632-04-4/10332-33-9/10486-00-7 [6] 231-556-4 [6]
Perboric acid, sodium salt [7] 11138-47-9 [7] 234-390-0 [7]
Perboric acid, sodium salt, monohydrate [8] 12040-72-1 [8] 234-390-0 [8]
Perboric acid (HBO(O2)), sodium salt, monohydrate [9] 10332-33-9 [2]
10486-00-7[2] 231-556-4 [2] [9] — [9]
Trimethyl borate 121-43-7 [10] 204-468-9 [10]
1398 Perboric acid (H3BO2(O2)), monosodium salt trihydrate [1] 13517-20-9 [1] 239-172-9 [1]
Perboric acid, sodium salt, tetrahydrate [2] 37244-98-7 [2] 234-390-0 [2]
Perboric acid (HBO(O2)), sodium salt, tetrahydrate sodium peroxoborate hexahydrate [3] 10486-00-7 [3] 231-556-4 [3]
1399 Perboric acid, sodium salt [1] 11138-47-9 … 2,747 unchanged words … Pentasodium Pentetate (INCI) 140-01-2 205-391-3
1722 Acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl)methyl]-N’-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine 135410-20-7/
160430-64-8 603-921-1/
682-791-8
1723 Pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidene 40487-42-1 254-938-2
1724 Bentazone (ISO); 3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide 25057-89-0 246-585-8
1725 Styrene/Acrylates copolymer (nano) [INCI]
Sodium Styrene/Acrylates copolymer (nano) [INCI] 9010-92-8 927-710-1
1726 Copper (nano) [INCI], Colloidal Copper (nano) [INCI] 7440-50-8 231-159-6
1727 Colloidal silver Silver (nano) [INCI] [1 nm < particle diameter ≤ 100 nm]
Silver (massive) [particle diameter ≥ 1 mm] 7440-22-4 231-131-3
1728 Gold (nano) [INCI], Colloidal Gold (nano) [INCI] [1]
Gold Thioethylamino Hyaluronic Acid (nano) [INCI] [2]
Acetyl heptapeptide-9 Colloidal gold (nano) [INCI] [3] 7440-57-5 [1]
1360157-34-1 [2]
[3] 231-165-9 [1]
[2]
[3]
1729 Platinum (nano) [INCI], Colloidal Platinum (nano) [INCI] [1]
Acetyl tetrapeptide-17 Colloidal Platinum (nano) [INCI] [2] 7440-06-4 [1]
[2] 231-116-1 [1]
[2]
1730 3-(4'-methylbenzylidene)-camphor;
[INCI: 4-Methylbenzylidene Camphor] 36861-47-9/38102-62-4 253-242-6/-
1731 diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide; INCI: Trimethylbenzoyl Diphenylphosphine Oxide 75980-60-8 278-355-8
1732 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol; tetrabromobisphenol-A 79-94-7 201-236-9
1733 transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl (1R,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 118712-89-3 405-060-5
1734 clothianidin (ISO); (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine 210880-92-5 433-460-1
1735 benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate 577705-90-9 479-100-5
1736 benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[phenol] (1:1) 75768-65-9 278-305-5
1737 reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate (1:1) - -
1738 reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol (1:1) - -
1739 dimethyl propylphosphonate 18755-43-6 242-555-3
1740 dibutyltin maleate 78-04-6 201-077-5
1741 dibutyltin oxide 818-08-6 212-449-1
1742 reaction mass of 1-(2,3-epoxypropoxy)-2,2-bis ((2,3-epoxypropoxy)methyl) butane and 1-(2,3-epoxypropoxy)-2-((2,3-epoxypropoxy)methyl)-2-hydroxymethyl butane - -
1743 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol; bisphenol AF 1478-61-1 216-036-7
1744 benfluralin (ISO); N-butyl-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine 1861-40-1 217-465-2
1745 N,N-dimethyl-p-toluidine 99-97-8 202-805-4
1746 1,4-Benzenediamine, N,N’-mixed Ph and tolyl derivs. 68953-84-4 273-227-8
1747 4-nitrosomorpholine 59-89-2 -
1748 difenoconazole (ISO); 1-({2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole; 3-chloro-4-[(2RS,4RS;2RS,4SR)-4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-yl]phenyl 4-chlorophenyl ether 119446-68-3 -
1749 4-methylimidazole 822-36-6 212-497-3
1750 3,3'-dimethylbiphenyl-4,4'-diyl diisocyanate 91-97-4 202-112-7
1751 foramsulfuron (ISO); 2-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-4-formamido-N,N-dimethylbenzamide; 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-dimethylcarbamoyl-5-formamidophenylsulfonyl)urea 173159-57-4 -1752 Multi-walled Carbon Tubes (synthetic graphite in tubular shape) with a geometric tube diameter range ≥ 30 nm to < 3 μm and a length ≥ 5 μm and aspect ratio > 3:1, including Multi-Walled Carbon Nanotubes, MWC(N)T — —
1753 reaction mass of 1,3-dioxan-5-ol and 1,3-dioxolan-4-ylmethanol — —
1754 Acetone oxime 127-06-0 204-820-1
1755 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one 119344-86-4 438-340-0
1756 2,3-epoxypropyl neodecanoate 26761-45-5 247-979-2
1757 Benthiavalicarb-isopropyl (ISO); isopropyl [(S)-1-{[(R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]carbamoyl}-2-methylpropyl]carbamate 177406-68-7 —
1758 7-oxabicyclo[4.1.0]hept-3-ylmethyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate 2386-87-0 219-207-4
1759 Sodium 3-(allyloxy)-2-hydroxypropanesulphonate 52556-42-0 258-004-5
1760 1,4-dichloro-2-nitrobenzene 89-61-2 201-923-3
1761 Fenpropidin (ISO); (R,S)-1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine 67306-00-7 —
1762 N,N’-methylenediacrylamide 110-26-9 203-750-9
1763 tert-butyl 2-ethylperoxyhexanoate 3006-82-4 221-110-7
1764 Trimethyl borate 121-43-7 204-468-9
1765 S-metolachlor (ISO); 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide; (RaSa)-2-chloro-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]acetamide [contains 80-100 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide and 0-20 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2R)-1-methoxypropan-2-yl]acetamide] 87392-12-9 —
1766 Pyraclostrobin (ISO); methyl N-(2-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl}phenyl) N-methoxy carbamate 175013-18-0 —
Annex III LIST OF SUBSTANCES WHICH COSMETIC PRODUCTS MUST NOT CONTAIN EXCEPT SUBJECT TO THE RESTRICTIONS LAID DOWN, Modified§
No explanation shipped — the difference between the two versions lies beyond the characters this stage can show, so no explanation was requested.
2 entries added, 3 amended, 0 removed.
4 rows carry no key and are not compared.
2 entries added
| Identifiers | Reference number | Substance identification | Restrictions | Wording of conditions of use and warnings | |||||
|---|---|---|---|---|---|---|---|---|---|
| Chemical name/INN | Name of Common Ingredients Glossary | CAS number | EC number | Product type, body parts | Maximum concentration in ready for use preparation | Other | |||
| a | b | c | d | e | f | g | h | i | |
| Reference number 379CAS 7440-22-4EC 231-131-3 | 379 | Silver (powder) [100 nm < particle diameter < 1 mm] | Silver | 7440-22-4 | 231-131-3 | (a) Toothpaste (b) Mouthwash | For (a) and (b): 0,05 % | ||
| Reference number 380CAS 6259-76-3EC 228-408-6 | 380 | Hexyl 2-hydroxybenzoate | Hexyl Salicylate | 6259-76-3 | 228-408-6 | (a) Hydroalcoholic-based fragrances (except hydroalcoholic-based fragrances intended for children below 3 years of age) (b) All rinse-off products (except shower gel/bath products, hand wash, hair conditioner and shampoo intended for children below 3 years of age) (c) All leave-on products (except hair conditioner, body lotion, face cream, hand cream, lipstick/lip balm and fragrance products intended for children below 3 years of age) (d) Toothpaste (e) Mouthwash (f) Shower gel/bath products, hand wash, shampoo, hair conditioner, body, face and hand (skin) care products, lipstick/lip balm and fragrance products intended for children below 3 years of age | (a) 2 % (b) 0,5 % (c) 0,3 % (d) 0,001 % (e) 0,001 % (f) 0,1 % | Not to be used in preparations for children under 3 years of age, with the exception of (d) Toothpaste and (f). | |
3 entries amended
| Identifiers | Version | Reference number | Substance identification | Restrictions | Wording of conditions of use and warnings | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Chemical name/INN | Name of Common Ingredients Glossary | CAS number | EC number | Product type, body parts | Maximum concentration in ready for use preparation | Other | ||||
| a | b | c | d | e | f | g | h | i | ||
| Reference number 157CAS 23696-85-7CAS 23726-91-2CAS 23726-92-3CAS 23726-94-5CAS 24720-09-0CAS 43052-87-5CAS 57378-68-4CAS 71048-82-3EC 245-833-2EC 245-842-1EC 245-843-7EC 245-845-8EC 246-430-4EC 260-709-8EC 275-156-8 | Before | 157 | Alpha-Damascone;
| 43052-87-5/
| -/
| (a) Oral products
| (b) 0,02 % | (a) (b) The presence of the substance or substances shall be indicated as Rose Ketones in the list of ingredients referred to in Article 19(1), point (g), when the concentration of the substance or substances exceeds: 0,001 % in leave-on products 0,01 % in rinse-off products. | ||
| Rose ketone | ||||||||||
| After | 157 | 1-(2,6,6-trimethyl-2- cyclohexen-1-yl)-2-buten-1-one | Alpha-Damascone; | 43052-87-5/ | -/ | (a) Oral products | (b) 0,02 % | (a) (b) The presence of the substance or substances shall be indicated as Rose Ketones in the list of ingredients referred to in Article 19(1), point (g), when the concentration of the substance or substances exceeds: 0,001 % in leave-on products 0,01 % in rinse-off products. | ||
| cis-Rose ketone 1 | 23726-94-5 | 245-845-8 | (b) Other products | |||||||
| trans-Rose ketone 1 | 24720-09-0 | 246-430-4 | ||||||||
| 1-(2,6,6-Trimethyl cyclohexa-1,3-dien-1-yl)-2-buten-1-one | Rose ketone 4 (Damascenone) | 23696-85-7 | 245-833-2 | |||||||
| 1-(2,6,6-Trimethyl- 3-cyclohexen-1-yl)-2-buten-1- one | Rose ketone 3(delta-Damascone) | 57378-68-4 | 260-709-8 | |||||||
| trans-Rose ketone 3 | 71048-82-3 | 275-156-8 | ||||||||
| (Z)-1-(2,6,6- trimethyl-1-cyclo hexen-1-yl)-2-buten-1-one | cis-Rose ketone 2 (cis-beta-Damascone) | 23726-92-3 | 245-843-7 | |||||||
| (E)-1-(2,6,6- Trimethyl-1-cyclo hexen-1-yl)-2-buten-1-one | trans-Rose ketone 2 (trans-beta-Damascone) | 23726-91-2 | 245-842-1 | |||||||
| Reference number 364CAS 8000-46-2CAS 90082-51-2EC 290-140-0 | Before | 364 | Pelargonium graveolens oil | Pelargonium Graveolens Flower Oil | 90082-51-2/ 8000-46-2 | 290-140-0/ - | The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds:
0,001 % in leave-on products
0,01 % in rinse-off | |||
| After | 364 | Pelargonium graveolens oil | Pelargonium Graveolens Oil Pelargonium Graveolens Flower OilPelargonium Graveolens Leaf Oil | 90082-51-2/ 8000-46-2 | 290-140-0/ - | The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: 0,001 % in leave-on products 0,01 % in rinse-off products | ||||
| Reference number 365CAS 8014-09-3CAS 84238-39-1EC 282-493-4 | Before | 365 | Pogostemon cablin oil | Pogostemon Cablin Oil | 8014-09-3/ 84238-39-1 | -/ 282-493-4 | The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds:
0,001 % in leave-on products
0,01 % in rinse-off | |||
| After | 365 | Pogostemon cablin oil | Pogostemon Cablin OilPogostemon Cablin Leaf Oil | 8014-09-3/ 84238-39-1 | -/ 282-493-4 | The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: 0,001 % in leave-on products 0,01 % in rinse-off products | ||||
Text from EUR-Lex, before and after
Previous version, in force 1 September 2025 02009R1223-20250901 → this version, in force 1 May 2026 02009R1223-20260501
compared line by line: this provision is too large to compare word by word, so a marked line is a line that changed somewhere
ANNEX III
LIST OF SUBSTANCES WHICH COSMETIC PRODUCTS MUST NOT CONTAIN EXCEPT SUBJECT TO THE RESTRICTIONS LAID DOWN
These substances may be used singly or in combination provided that the sum of the ratios of the levels of each of them in the cosmetic product expressed with reference to the maximum level authorised for each of them does not exceed 1.For use as a preservative, see Annex V, No. 5.Only if the concentration exceeds 0,05 %.These substances may be used singly or in combination provided that the sum of the ratios of the levels of each of them in the cosmetic product expressed with reference to the maximum level authorised for each of them does not exceed 2.The quantity of sodium, potassium or lithium hydroxide is expressed as weight of sodium hydroxide. In cases of mixtures, the sum should not exceed the limits given in column g.The concentration of sodium, potassium or lithium hydroxide is expressed as weight of sodium hydroxide. In case of mixtures, the sum should not exceed the limits given in column g.For use as a preservative, see Annex V, No. 34.For use as a preservative, see Annex V, No 43.For use as a preservative, see Annex V, No. 54.For use as a preservative see Annex V, No 3.Solely for products which might be used for children under 3 years of age.For use as a preservative, see Annex V, No 9.For use as a preservative, see AnnexV, No 23.For use as a preservative, see Annex V, No 8.Directive 2005/36/EC of the European Parliament and of the Council of 7 September 2005 on the recognition of professional qualifications (OJ L 255, 30.9.2005, p. 22).This limit applies to the substance and not to the finished cosmetic product.The sum of those substances used in combination should not exceed the limits given as Maximum concentration in ready for use preparation.The free base and salts of this hair colouring ingredient, unless prohibited under Annex II, are permitted for use.For use as a preservative, see Annex V, No 58.For use as a preservative, see Annex V, entry No 44.For other uses of potassium hydroxide, see Annex III, No 15d.For other uses of potassium hydroxide, see Annex III, No 15a.From 25 September 2018 cosmetic products containing peanut oil, extracts and derivatives and not complying with that restriction shall not be placed on the Union market. From 25 December 2018 cosmetic products containing peanut oil, extracts and derivatives and not complying with that restriction shall not be made available on the Union market.From 25 September 2018 cosmetic products containing hydrolyzed wheat proteins and not complying with that restriction shall not be placed on the Union market. From 25 December 2018 cosmetic products containing hydrolyzed wheat proteins and not complying with that restriction shall not be made available on the Union market.From 1 May 2019 cosmetic products containing that substance and not complying with the restrictions shall not be placed on the Union market. From 1 August 2019 cosmetic products containing that substance and not complying with the restrictions shall not be made available on the Union market.From 1 May 2019 cosmetic products containing that substance and not complying with the restrictions shall not be placed on the Union market. From 1 August 2019 cosmetic products containing that substance and not complying with the restrictions shall not be made available on the Union market.From 1 May 2019 cosmetic products containing that substance and not complying with the restrictions shall not be placed on the Union market. From 1 August 2019 cosmetic products containing that substance and not complying with the restrictions shall not be made available on the Union market.From 1 May 2019 cosmetic products containing that substance and not complying with the restrictions shall not be placed on the Union market. From 1 August 2019 cosmetic products containing that substance and not complying with the restrictions shall not be made available on the Union market.For use as a preservative, see Annex V, entry 32.From 27 November 2019 cosmetic products containing 1-(4-Chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethylbutan-2-one and not complying with those restrictions shall not be placed on the Union market.
… 602 unchanged lines …
Cuminum Cyminum Fruit Extract;
Cuminum Cyminum Seed Oil;
Cuminum Cyminum Seed Extract;
Cuminum Cyminum Seed Powder 84775-51-9 283-881-6 (a) Leave-on products (a) 0,4 % of Cumin oil (b) Rinse-off products 157 1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-buten-1-one Alpha-Damascone;
cis-Rose ketone 1 43052-87-5/
23726-94-5 -/
245-845-8 (a) Oral products
(b) Other products (b) 0,02 % (a) (b) Cuminum Cyminum Seed Powder 84775-51-9 283-881-6 (a) Leave-on products (a) 0,4 % of Cumin oil (b) Rinse-off products 157 1-(2,6,6-trimethyl-2- cyclohexen-1-yl)-2-buten-1-one Alpha-Damascone; 43052-87-5/ -/ (a) Oral products (b) 0,02 % (a) (b)
The presence of the substance or substances shall be indicated as Rose Ketones in the list of ingredients referred to in Article 19(1), point (g), when the concentration of the substance or substances exceeds:
0,001 % in leave-on products
0,01 % in rinse-off products. trans-Rose ketone 1 24720-09-0 246-430-4
1-(2,6,6-Trimethylcyclohexa-1,3-dien-1-yl)-2-buten-1-one Rose ketone 4 (Damascone) 23696-85-7 245-833-2
1-(2,6,6-Trimethyl-3-cyclohexen-1-yl)-2-buten-1-one Rose ketone 3 (delta-Damascone) 57378-68-4 260-709-8 0,001 % in leave-on products
0,01 % in rinse-off products. cis-Rose ketone 1 23726-94-5 245-845-8 (b) Other products
trans-Rose ketone 1 24720-09-0 246-430-4
1-(2,6,6-Trimethyl cyclohexa-1,3-dien-1-yl)-2-buten-1-one Rose ketone 4 (Damascenone) 23696-85-7 245-833-2
1-(2,6,6-Trimethyl- 3-cyclohexen-1-yl)-2-buten-1- one Rose ketone 3 (delta-Damascone) 57378-68-4 260-709-8
trans-Rose ketone 3 71048-82-3 275-156-8
(Z)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-buten-1-one cis-Rose ketone 2 (Z)-1-(2,6,6- trimethyl-1-cyclo hexen-1-yl)-2-buten-1-one cis-Rose ketone 2
(cis-beta-Damascone) 23726-92-3 245-843-7
(E)-1-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-2-buten-1-one trans-Rose ketone 2 (E)-1-(2,6,6- Trimethyl-1-cyclo hexen-1-yl)-2-buten-1-one trans-Rose ketone 2
(trans-beta-Damascone) 23726-91-2 245-842-1
158 trans-Rose ketone-2; (E)-1-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-2-buten-1-one (trans-beta-Damascone) trans-Rose ketone-2 23726-91-2 245-842-1 (a) Oral products (b) Other products (b) 0,02 %
159 trans-Rose ketone-5; (E)-1-(2,4,4-Trimethyl-2-cyclohexen-1-yl)-2-buten-1-one (Isodamascone) trans-Rose ketone-5 39872-57-6 254-663-8 0,02 % 160 Rose ketone-4; 1-(2,6,6-Trimethylcyclohexa-1,3-dien-1-yl)-2-buten-1-one (Damascenone) Rose ketone-4 23696-85-7 245-833-2 (a) Oral products (b) Other products (b) 0,02 %
… 1,396 unchanged lines …
0,01 % in rinse-off products. Narcissus Pseudonarcissus Flower Extract 90064-27-0 290-088-9
Narcissus Jonquilla Extract
Narcissus Tazetta Extract 90064-25-8 290-086-8
364 Pelargonium graveolens oil Pelargonium Graveolens Flower Oil 90082-51-2/
8000-46-2 290-140-0/ - The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds:
0,001 % in leave-on products
0,01 % in rinse-off products. 365 Pogostemon cablin oil Pogostemon Cablin Oil 8014-09-3/ 84238-39-1 -/
282-493-4 The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds:
0,001 % in leave-on products
0,01 % in rinse-off products. 366 Rosa damascena flower oil/extract; Rosa Damascena Flower Oil; Rosa Damascena Flower Extract 8007-01-0/ 364 Pelargonium graveolens oil Pelargonium Graveolens Oil
Pelargonium Graveolens Flower Oil
Pelargonium Graveolens Leaf Oil 90082-51-2/ 8000-46-2 290-140-0/ - The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds:
0,001 % in leave-on products
0,01 % in rinse-off products 365 Pogostemon cablin oil Pogostemon Cablin Oil
Pogostemon Cablin Leaf Oil 8014-09-3/ 84238-39-1 -/ 282-493-4 The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds:
0,001 % in leave-on products
0,01 % in rinse-off products 366 Rosa damascena flower oil/extract; Rosa Damascena Flower Oil; Rosa Damascena Flower Extract 8007-01-0/
90106-38-0/ -/
290-260-3 The presence of the substance or substances shall be indicated as Rose Flower Oil/Extract in the list of ingredients referred to in Article 19(1), point (g), when the concentration of the substance or substances exceeds:
0,001 % in leave-on products
… 38 unchanged lines …
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate Retinyl Palmitate 79-81-2 201-228-5
377 4-Hydroxyphenyl-alpha-D-glucopyranoside Alpha-Arbutin 84380-01-8 617-561-8 (a) Face cream
(b) Body lotion (a) 2 %
(b) 0,5 % Hydroquinone levels shall remain as low as possible in formulations containing alpha-Arbutin and shall not be higher than the unavoidable trace level. 378 4-Hydroxyphenyl-beta-D-glucopyranoside Arbutin 497-76-7 207-850-3 Face cream 7 % Hydroquinone levels shall remain as low as possible in formulations containing Arbutin and shall not be higher than the unavoidable trace level. (b) 0,5 % Hydroquinone levels shall remain as low as possible in formulations containing alpha-Arbutin and shall not be higher than the unavoidable trace level. 378 4-Hydroxyphenyl-beta-D-glucopyranoside Arbutin 497-76-7 207-850-3 Face cream 7 % Hydroquinone levels shall remain as low as possible in formulations containing Arbutin and shall not be higher than the unavoidable trace level. 379 Silver (powder) [100 nm < particle diameter < 1 mm] Silver 7440-22-4 231-131-3 (a) Toothpaste
(b) Mouthwash For (a) and (b): 0,05 % 380 Hexyl 2-hydroxybenzoate Hexyl Salicylate 6259-76-3 228-408-6 (a) Hydroalcoholic-based fragrances (except hydroalcoholic-based fragrances intended for children below 3 years of age)
(b) All rinse-off products (except shower gel/bath products, hand wash, hair conditioner and shampoo intended for children below 3 years of age)
(c) All leave-on products (except hair conditioner, body lotion, face cream, hand cream, lipstick/lip balm and fragrance products intended for children below 3 years of age)
(d) Toothpaste
(e) Mouthwash
(f) Shower gel/bath products, hand wash, shampoo, hair conditioner, body, face and hand (skin) care products, lipstick/lip balm and fragrance products intended for children below 3 years of age (a) 2 %
(b) 0,5 %
(c) 0,3 %
(d) 0,001 %
(e) 0,001 %
(f) 0,1 % Not to be used in preparations for children under 3 years of age, with the exception of (d) Toothpaste and (f).
Annex IV LIST OF COLORANTS ALLOWED IN COSMETIC PRODUCTS, Modified§
Explanation, written by a model and checked against the cited text
Entry 142 for Silver was changed from a general listing with no product type or maximum concentration restriction to one that specifies the substance as a powder with a particle diameter range between 100 nm and 1 mm, adds a CAS number, and limits use to lip products and eye shadow at a maximum concentration of 0,2 % for each.
Cited: Annex IV, v1 (external, EUR-Lex) · Annex IV, v2 (external, EUR-Lex)
v1 is the previous version, v2 this one.
0 entries added, 1 amended, 0 removed.
1 entry amended
| Identifiers | Version | Reference number | Substance identification | Conditions | Wording of conditions of use and warnings | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemical Name | Colour index Number/Name of Common Ingredients Glossary | CAS number | EC number | Colour | Product type, Body parts | Maximum concentration in ready for use preparation | Other | ||||
| a | b | c | d | e | f | g | h | i | j | ||
| Reference number 142CAS 7440-22-4EC 231-131-3 | Before | 142 | Silver | 77820 | 231-131-3 | White | |||||
| After | 142 | Silver(powder) [100 nm < particle diameter < 1 mm] | 77820 | 7440-22-4 | 231-131-3 | White | (a) Lip products (b) Eye shadow | For (a) and (b): 0,2 % | |||
Text from EUR-Lex, before and after
Previous version, in force 1 September 2025 02009R1223-20250901 → this version, in force 1 May 2026 02009R1223-20260501
ANNEX IV
LIST OF COLORANTS ALLOWED IN COSMETIC PRODUCTS
Preamble
Without prejudice to other provisions in this Regulation, a colorant shall include its salts and lakes and when a colorant is expressed as a specific salt, its other salts and lakes shall also … 1,914 unchanged words … Purity criteria as set out in Commission Directive 95/45/EC (E 172) 138 Ferric Ammonium Ferrocyanide 77510 Blue free from cyanide ions 139 Magnesium carbonate 77713 White 140 Ammonium manganese(3+) diphosphate 77742 Violet 141 Trimanganese bis (orthophosphate) 77745 Red 142 Silver (powder) [100 nm < particle diameter < 1 mm] 77820 7440-22-4 231-131-3 White Purity criteria as set out in Commission Directive 95/45/EC (E 174) (a) Lip products
(b) Eye shadow For (a) and (b): 0,2 % 143 Titanium dioxide
77891 236-675-5 White Purity criteria as set out in Commission Directive 95/45/E (E 171)
Titanium dioxide in powder form containing 1 % or more of particles with aerodynamic diameter ≤ 10 μm, to be used in compliance with Annex III, No 321 144 Zinc oxide
77947 1314-13-2 215-222-5 White Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation. 145 Riboflavin Lactoflavin 201-507-1/204-988-6 Yellow Purity criteria as set out in Commission Directive 95/45/EC (E 101) 146 Caramel Caramel 232-435-9 Brown Purity criteria as set out in Commission Directive 95/45/EC (E 150a-d) 147 Paprika extract, Capsanthin, capsorubin Capsanthin, capsorubin 207-364-1/207-425-2 Orange Purity criteria as set out in Commission Directive 95/45/EC (E 160c) 148 Beetroot red Beetroot Red 7659-95-2 231-628-5 Red Purity criteria as set out in Commission Directive 95/45/EC (E 162) 149 Anthocyanins
(Cyanidin,
Peonidin
Malvidin
Delphinidin
Petunidin
Pelargonidin) Anthocyanins 528-58-5
134-01-0
528-53-0
643-84-5
134-04-3 208-438-6
205-125-6
211-403-8
208-437-0
—
205-127-7 Red Purity criteria as set out in Commission Directive 95/45/EC (E 163) 150 Aluminium, zinc, magnesium and calcium stearates Aluminum stearate
Zinc stearate
Magnesium stearate
Calcium stearate 7047-84-9
557-05-1
557-04-0
216-472-8 230-325-5
209-151-9
209-150-3
216-472-8 White 151 Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[2-bromo-3-methyl-6-(1-methylethyl)-, S,S-dioxide Bromothymol blue 76-59-5 200-971-2 Blue Rinse-off products 152 Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-3-methyl-,S,S-dioxide Bromocresol green 76-60-8 200-972-8 Green Rinse-off products 153 Sodium 4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxynaphthalene-1-sulphonate Acid red 195 12220-24-5 — Red Not to be used in products applied on mucous membranes
Annex V LIST OF PRESERVATIVES ALLOWED IN COSMETIC PRODUCTS, Modified§
Explanation, written by a model and checked against the cited text
Entry 7 now covers Biphenyl-2-ol (o-Phenylphenol) together with a second substance, Sodium 2-biphenylate (Sodium o-Phenylphenate), adding its CAS and EC numbers alongside the original ones.
The product-type and body-part column is restated as rinse-off and leave-on categories with the same maximum concentrations as phenol, but a new condition sets a combined maximum concentration when both substances are used together in the same product.
The wording of conditions of use and warnings for entry 7 is expanded to add restrictions on lung-exposure applications and oral products, in addition to the existing warning to avoid contact with eyes.
Cited: Annex V, v2 (external, EUR-Lex) · Annex V, v1 (external, EUR-Lex)
v1 is the previous version, v2 this one.
0 entries added, 1 amended, 0 removed.
1 entry amended
| Identifiers | Version | Reference number | Substance identification | Conditions | Wording of conditions of use and warnings | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Chemical name/INN | Name of Common Ingredients Glossary | CAS number | EC number | Product type, Body parts | Maximum concentration in ready for use preparation | Other | ||||
| a | b | c | d | e | f | g | h | i | ||
| Reference number 7CAS 132-27-4CAS 90-43-7EC 201-993-5EC 205-055-6 | Before | 7 | o-Phenylphenol | 90-43-7 | 201-993-5 | (a) Rinse-off | (a) 0,2 % (as phenol) | Avoid contact with eyes | ||
| After | 7 | Biphenyl-2-ol; 2-phenylphenol; 2-hydroxybiphenyl Sodium 2-biphenylate | o-PhenylphenolSodium o-Phenylphenate | 90-43-7132-27-4 | 201-993-5205-055-6 | (a) Rinse-off products (b) Leave-on products | (a) 0,2 % (as phenol (b) 0,15 % (as phenol) | When o-Phenylphenol and Sodium o-Phenylphenate are used together, the combined concentration (as phenol) shall not exceed 0,2 % in rinse-off and 0,15 % in leave-on products. Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products. | Avoid contact with eyes | |
Text from EUR-Lex, before and after
Previous version, in force 1 September 2025 02009R1223-20250901 → this version, in force 1 May 2026 02009R1223-20260501
ANNEX V
LIST OF PRESERVATIVES ALLOWED IN COSMETIC PRODUCTS
Preamble
1. For the purposes of this list:
Salts is taken to mean: salts of the cations sodium, potassium, calcium, magnesium, ammonium and ethanolamines; salts of the anions chloride, bromide, sulphate, acetate.
Esters is taken to … 826 unchanged words … 110-44-1, 7492-55-9, 7757-81-5, 24634-61-5 203-768-7, 231-321-6, 231-819-3, 246-376-1 0,6 % (acid) 5 Formal-dehyde, paraformaldehyde
Formaldehyde
Paraformaldehyde 50-00-0, 30525-89-4 200-001-8 Oral products 0,1 % (free formaldehyde) Not to be used in aerosol dispensers (sprays) Other products 0,2 % (free formaldehyde)
6 Moved or deleted
7 Biphenyl-2-ol Biphenyl-2-ol; 2-phenylphenol; 2-hydroxybiphenyl
Sodium 2-biphenylate o-Phenylphenol Sodium o-Phenylphenate 90-43-7 132-27-4 201-993-5 205-055-6 (a) Rinse-off Products products
(b) Leave-on products (a) 0,2 % (as phenol) Avoid contact with eyes
(b) Leave-on products phenol
(b) 0,15 % (as phenol)
When o-Phenylphenol and Sodium o-Phenylphenate are used together, the combined concentration (as phenol) shall not exceed 0,2 % in rinse-off and 0,15 % in leave-on products.
Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Not to be used in oral products. Avoid contact with eyes
8 Pyrithione zinc
Zinc pyrithione 13463-41-7 236-671-3 Hair products 1,0 % Only in rinse-off products
Not to be used in oral products Other products 0,5 %
9 Inorganic sulphites and hydrogen- sulphites
Sodium sulfite, ammonium bisulfite, ammonium sulfite, potassium sulfite, potassium hydrogen sulfite, sodium … 1,189 unchanged words … and 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, silver(1+) salt, monohydrate Citric acid (and) Silver citrate — 460-890-5 0,2 %, corresponding to 0,0024 % of silver Not to be used in oral products and eye products 60 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one Hydroxyethoxyphenyl Butanone 569646-79-3 933-435-8 0,7 %
The full entry is committed at eu/32009R1223/CHANGELOG.md.